Open Access

Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17

  • Authors:
    • Giulio Kleiner
    • Valentina Zanin
    • Lorenzo Monasta
    • Sergio Crovella
    • Lorenzo Caruso
    • Daniela Milani
    • Annalisa Marcuzzi
  • View Affiliations

  • Published online on: March 19, 2015     https://doi.org/10.3892/etm.2015.2370
  • Pages: 2047-2052
  • Copyright: © Kleiner et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Inflammatory bowel disease (IBD) is a chronic and progressive inflammatory condition of the gastrointestinal tract. Although the causative events that lead to the onset of IBD are yet to be fully elucidated, deregulation of immune and inflammatory mechanisms are hypothesized to significantly contribute to this disorder. Since the onset of IBD is often during infancy, in the present study, the serum values of a large panel of cytokines and chemokines in pediatric patients (<18 years; n=26) were compared with age‑matched controls (n=37). While elevations in the serum level of several proinflammatory and immune regulating cytokines were confirmed, such as interleukin (IL)‑1β, IL‑5, IL‑7, interferon (IFN)‑γ‑inducible protein‑10, IL‑16, cutaneous T‑cell‑attracting chemokine, leukemia inhibitory factor, monokine induced by γ‑IFN, IFN‑α2 and IFN‑γ, notably decreased levels of IL‑2, IL‑17 and macrophage inhibitory protein‑1β were also observed. Therefore, while a number of proinflammatory cytokines exhibit increased levels in IBD patients, pediatric IBD patients may also exhibit certain aspects of a reduced immunological response.
View Figures
View References

Related Articles

Journal Cover

June-2015
Volume 9 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kleiner G, Zanin V, Monasta L, Crovella S, Caruso L, Milani D and Marcuzzi A: Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17. Exp Ther Med 9: 2047-2052, 2015.
APA
Kleiner, G., Zanin, V., Monasta, L., Crovella, S., Caruso, L., Milani, D., & Marcuzzi, A. (2015). Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17. Experimental and Therapeutic Medicine, 9, 2047-2052. https://doi.org/10.3892/etm.2015.2370
MLA
Kleiner, G., Zanin, V., Monasta, L., Crovella, S., Caruso, L., Milani, D., Marcuzzi, A."Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17". Experimental and Therapeutic Medicine 9.6 (2015): 2047-2052.
Chicago
Kleiner, G., Zanin, V., Monasta, L., Crovella, S., Caruso, L., Milani, D., Marcuzzi, A."Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17". Experimental and Therapeutic Medicine 9, no. 6 (2015): 2047-2052. https://doi.org/10.3892/etm.2015.2370